SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-290294
Filing Date
2020-11-10
Accepted
2020-11-10 17:07:37
Documents
53
Period of Report
2020-09-27

Document Format Files

Seq Description Document Type Size
1 10-Q d939086d10q.htm   iXBRL 10-Q 707230
2 EX-2.1 d939086dex21.htm EX-2.1 12875
3 EX-31.1 d939086dex311.htm EX-31.1 7051
4 EX-31.2 d939086dex312.htm EX-31.2 6900
5 EX-32.1 d939086dex321.htm EX-32.1 3375
6 EX-32.2 d939086dex322.htm EX-32.2 3561
12 GRAPHIC g939086g85i86.jpg GRAPHIC 18356
  Complete submission text file 0001193125-20-290294.txt   2980340

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ck0001792044-20200927.xsd EX-101.SCH 29155
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001792044-20200927_cal.xml EX-101.CAL 23157
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001792044-20200927_def.xml EX-101.DEF 116789
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001792044-20200927_lab.xml EX-101.LAB 172459
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001792044-20200927_pre.xml EX-101.PRE 171079
13 EXTRACTED XBRL INSTANCE DOCUMENT d939086d10q_htm.xml XML 411324
Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 (212) 733-2323
Upjohn Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39695 | Film No.: 201302062
SIC: 2834 Pharmaceutical Preparations